Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Ketones and Niacin in Heart Failure Patients
NCT04703361Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Feb 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of 3-hydroxybutyrate in heart failure with reduced ejection fraction (HFrEF) (2 arms), sponsored by Aarhus University. Primary endpoint: Cardiac Output at 3 hours. Started Feb 2021; status: completed.
02
Drugs
3-hydroxybutyrate
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT04703361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04703361.